We designed and initiated a single‐arm clinical trial (phase Ib) to evaluate the simultaneous administration of dexamethasone and cyclosporine with anti‐CD41‐PLT‐VP16 in HLH patients (reference number: 3923‐435‐02). This evidence concerns the gene ITGA2B and hemophagocytic syndrome.